Atomistry » Chlorine » PDB 4wcu-4wki » 4wk7
Atomistry »
  Chlorine »
    PDB 4wcu-4wki »
      4wk7 »

Chlorine in PDB 4wk7: Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide)

Enzymatic activity of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide)

All present enzymatic activity of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide):
3.4.24.82;

Protein crystallography data

The structure of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide), PDB code: 4wk7 was solved by J.D.Durbin, S.L.Stout, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 13.72 / 1.24
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 40.506, 67.923, 74.581, 90.00, 90.00, 90.00
R / Rfree (%) 19.6 / 21.3

Other elements in 4wk7:

The structure of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide) also contains other interesting chemical elements:

Calcium (Ca) 3 atoms
Zinc (Zn) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide) (pdb code 4wk7). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide), PDB code: 4wk7:

Chlorine binding site 1 out of 1 in 4wk7

Go back to Chlorine Binding Sites List in 4wk7
Chlorine binding site 1 out of 1 in the Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide)


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl505

b:17.4
occ:1.00
CL1 A:3PQ505 0.0 17.4 1.0
C18 A:3PQ505 1.7 16.4 1.0
C20 A:3PQ505 2.7 16.1 1.0
C17 A:3PQ505 2.7 16.3 1.0
CG2 A:VAL398 3.7 19.7 1.0
O A:VAL390 3.7 11.9 1.0
CB A:PHE357 3.8 12.5 1.0
CA A:VAL390 3.9 12.7 1.0
C21 A:3PQ505 4.0 16.0 1.0
C16 A:3PQ505 4.0 16.2 1.0
CG A:MET395 4.0 20.0 1.0
O A:HOH709 4.0 27.6 1.0
CD1 A:PHE357 4.2 14.5 1.0
C A:VAL390 4.3 12.2 1.0
O A:PHE357 4.3 10.9 1.0
CG A:PHE357 4.4 13.8 1.0
O A:HIS389 4.4 14.0 1.0
CA A:MET395 4.5 19.5 1.0
C15 A:3PQ505 4.5 16.1 1.0
C A:PHE357 4.5 10.9 1.0
O A:ALA396 4.6 21.0 1.0
CB A:MET395 4.6 19.7 1.0
CA A:PHE357 4.6 11.7 1.0
CG1 A:VAL390 4.7 12.6 1.0
CB A:VAL390 4.7 12.8 1.0
CG2 A:VAL390 4.8 13.0 1.0
N A:VAL390 4.8 13.4 1.0
N A:ALA396 4.9 20.6 1.0
C A:HIS389 4.9 14.8 1.0
CE A:MET395 4.9 19.8 1.0

Reference:

T.B.Durham, V.J.Klimkowski, C.J.Rito, J.Marimuthu, J.L.Toth, C.Liu, J.D.Durbin, S.L.Stout, L.Adams, C.Swearingen, C.Lin, M.G.Chambers, K.Thirunavukkarasu, M.R.Wiley. Identification of Potent and Selective Hydantoin Inhibitors of Aggrecanase-1 and Aggrecanase-2 That Are Efficacious in Both Chemical and Surgical Models of Osteoarthritis. J.Med.Chem. 2014.
ISSN: ISSN 0022-2623
PubMed: 25415648
DOI: 10.1021/JM501522N
Page generated: Fri Jul 26 02:56:17 2024

Last articles

Cl in 6COG
Cl in 6CST
Cl in 6CTW
Cl in 6CTZ
Cl in 6CTT
Cl in 6CSP
Cl in 6CU9
Cl in 6CTX
Cl in 6CTU
Cl in 6CTP
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy